Skip to main content

Table 5 Sensitivity analyses for the association between cumulative CVAI indicators and CVD.

From: Association of the time course of Chinese visceral adiposity index accumulation with cardiovascular events in patients with hypertension

Index

Sensitivity analysisa

Sensitivity analysisb

Sensitivity analysisc

Sensitivity analysisd

CumCVAI

   

Quartile 1

Reference

Reference

Reference

Reference

Quartile 2

1.21(1.01–1.45)

1.16(0.96–1.41)

1.31(1.06–1.62)

1.19(0.99–1.44)

Quartile 3

1.29(1.07–1.54)

1.25(1.03–1.52)

1.41(1.14–1.74)

1.30(1.08–1.57)

Quartile 4

1.35(1.13–1.61)

1.33(1.10–1.61)

1.42(1.15–1.74)

1.36(1.14–1.63)

TWA-CVAI

Quartile 1

Reference

Reference

Reference

Reference

Quartile 2

1.08(0.90–1.30)

1.07(0.88–1.31)

1.09(0.88–1.35)

1.06(0.88–1.28)

Quartile 3

1.26(1.06–1.51)

1.27(1.05–1.54)

1.34(1.09–1.65)

1.27(1.06–1.52)

Quartile 4

1.35(1.13–1.61)

1.35(1.12–1.62)

1.49(1.22–1.82)

1.35(1.14–1.61)

Cumulative burden of CVAI

   

= 0

Reference

Reference

Reference

Reference

> 0

1.24(1.10–1.40)

1.27(1.11–1.44)

1.32(1.15–1.52)

1.26(1.12–1.43)

Time exposure duration

   

0 year

Reference

Reference

Reference

Reference

2 years

1.21(0.98–1.48)

1.30(1.04–1.62)

1.28(1.00-1.63)

1.23(1.00-1.52)

4 years

1.17(0.95–1.44)

1.13(0.89–1.42)

1.19(0.92–1.53)

1.19(0.96–1.47)

6 years

1.38(1.13–1.70)

1.39(1.12–1.73)

1.40(1.10–1.79)

1.39(1.13–1.71)

8 years

1.41(1.14–1.73)

1.42(1.14–1.78)

1.46(1.14–1.87)

1.43(1.14–1.79)

10 years

1.42(1.14–1.78)

1.45(1.14–1.84)

1.47(1.15–1.87)

1.45(1.18–1.79)

Index

Sensitivity analysis a

Sensitivity analysis b

Sensitivity analysis c

Sensitivity analysis d

Combination of CumCVAI and CVAI slope

CumCVAI < median, Slope < 0

Reference

Reference

Reference

Reference

CumCVAI < median, Slope ≥ 0

1.01(0.84–1.22)

1.07(0.87–1.30)

1.07(0.87–1.30)

1.02(0.84–1.23)

CumCVAI ≥ median, Slope < 0

1.11(0.91–1.35)

1.15(0.93–1.42)

1.15(0.93–1.42)

1.13(0.93–1.38)

CumCVAI ≥ median, Slope ≥ 0

1.22(1.03–1.46)

1.28(1.06–1.55)

1.28(1.06–1.55)

1.26(1.06–1.51)

  1. a Sensitivity analysis was performed using competing risk model considering death as a competing risk
  2. b Sensitivity analysis was performed by excluding outcome within the first year of follow-up
  3. c Sensitivity analysis was performed by attending consecutive health-check in 2006–2014 survey
  4. d Sensitivity analysis was performed by excluding participants with history of hepatitis at baseline
  5. Model 1: adjusted for age and sex;
  6. Model 2: adjusted for age, sex, smoking status, drinking status, education, and physical activity;
  7. Model 3: further adjusted for SBP, eGFR, hs-CRP, FBG, LDL-c, Antidiabetic agents, Antihypertensive agents, Lipid-lowering agents;